H
HexemBio
Raised $10.4M in a Seed round, announced 6 April 2026.
Round
HexemBio raised $10.4 million in seed funding for stem cell rejuvenation research, as reported by Axios.
- Amount
- $10.4M
- Stage
- Seed
- Announced
- 6 April 2026
- Lead
- Draper Associates
- Other investors
- SOSV, Seraphim
- Checked
- Amount and date checked against the press source
Company
Develops stem cell rejuvenation technology for therapeutic applications.
- Based in
- Berkeley
- Sector
- Health
- Website
- hexemb.io ↗
Founders
- Gabriel Levesque TremblayCEOLinkedIn ↗
- Samira Kianico-founder and CTOLinkedIn ↗
- Mo Ebrahimkhanico-founder and CSO
- Joshua Hislopco-founder, leads AI platform
